Implementation of Genetic Screening to Prevent Severe Cutaneous Adverse Drug Reactions Is Crucial—Rebuttal From the Devil’s Antagonist—Reply
Year: 2019
Type: letter
Source: JAMA Dermatology
Author: Sherrie J. Divito
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W2994932973
